These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33841446)

  • 21. Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins.
    Ali YM; Ferrari M; Lynch NJ; Yaseen S; Dudler T; Gragerov S; Demopulos G; Heeney JL; Schwaeble WJ
    Front Immunol; 2021; 12():714511. PubMed ID: 34290717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population.
    Cyprian FS; Suleman M; Abdelhafez I; Doudin A; Masud Danjuma M; Mir FA; Parray A; Yousaf Z; Siddiqui MYA; Abdelmajid A; Mulhim M; Al-Shokri S; Abukhattab M; Shaheen R; Elkord E; Al-Khal AL; Elzouki AN; Girardi G
    Front Immunol; 2021; 12():707159. PubMed ID: 34966381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the Relationship between Mortality and Troponin I Levels in Hospitalized Patients with the Novel Coronavirus (COVID-19).
    Özyılmaz S; Ergün Alış E; Ermiş E; Allahverdiyev S; Uçar H
    Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33322097
    [No Abstract]   [Full Text] [Related]  

  • 24. Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019.
    Castanha PMS; Tuttle DJ; Kitsios GD; Jacobs JL; Braga-Neto U; Duespohl M; Rathod S; Marti MM; Wheeler S; Naqvi A; Staines B; Mellors J; Morris A; McVerry BJ; Shah F; Schaefer C; Macatangay BJC; Methe B; Fernandez CA; Barratt-Boyes SM; Burke D; Marques ETA
    J Infect Dis; 2022 Sep; 226(5):766-777. PubMed ID: 35267024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
    Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
    Front Immunol; 2021; 12():581469. PubMed ID: 33664741
    [No Abstract]   [Full Text] [Related]  

  • 26. Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection.
    Avraham M; Sinkovits G; Hurler L; Prohászka Z; Fishelson Z
    Front Immunol; 2024; 15():1337215. PubMed ID: 38715618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of SARS-CoV-2 viral load at admission with in-hospital acute kidney injury: A retrospective cohort study.
    Paranjpe I; Chaudhary K; Johnson KW; Jaladanki SK; Zhao S; De Freitas JK; Pujdas E; Chaudhry F; Bottinger EP; Levin MA; Fayad ZA; Charney AW; Houldsworth J; Cordon-Cardo C; Glicksberg BS; Nadkarni GN
    PLoS One; 2021; 16(2):e0247366. PubMed ID: 33626098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 PCR cycle threshold at hospital admission associated with patient mortality.
    Choudhuri J; Carter J; Nelson R; Skalina K; Osterbur-Badhey M; Johnston A; Goldstein D; Paroder M; Szymanski J
    PLoS One; 2020; 15(12):e0244777. PubMed ID: 33382805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19.
    Turgutalp K; Ozturk S; Arici M; Eren N; Gorgulu N; Islam M; Uzun S; Sakaci T; Aydin Z; Sengul E; Demirelli B; Ayar Y; Altiparmak MR; Sipahi S; Mentes IB; Ozler TE; Oguz EG; Huddam B; Hur E; Kazancioglu R; Gungor O; Tokgoz B; Tonbul HZ; Yildiz A; Sezer S; Odabas AR; Ates K
    BMC Nephrol; 2021 Jan; 22(1):29. PubMed ID: 33446135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement(ing) long-COVID thromboinflammation and pathogenesis.
    Lee JD; Woodruff TM
    Trends Immunol; 2024 Jun; 45(6):397-399. PubMed ID: 38637200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation-associated factors for predicting in-hospital mortality in patients with COVID-19.
    Wang JH; Chen RD; Yang HK; Zeng LC; Chen H; Hou YY; Hu W; Yu JS; Li H
    J Med Virol; 2021 May; 93(5):2908-2917. PubMed ID: 33393678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation.
    Yan B; Freiwald T; Chauss D; Wang L; West E; Mirabelli C; Zhang CJ; Nichols EM; Malik N; Gregory R; Bantscheff M; Ghidelli-Disse S; Kolev M; Frum T; Spence JR; Sexton JZ; Alysandratos KD; Kotton DN; Pittaluga S; Bibby J; Niyonzima N; Olson MR; Kordasti S; Portilla D; Wobus CE; Laurence A; Lionakis MS; Kemper C; Afzali B; Kazemian M
    Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33827897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients.
    Dupont T; Caillat-Zucman S; Fremeaux-Bacchi V; Morin F; Lengliné E; Darmon M; Peffault de Latour R; Zafrani L; Azoulay E; Dumas G
    Chest; 2021 May; 159(5):1884-1893. PubMed ID: 33316234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of complement pathways with COVID-19 severity and outcomes.
    Devalaraja-Narashimha K; Ehmann PJ; Huang C; Ruan Q; Wipperman MF; Kaplan T; Liu C; Afolayan S; Glass DJ; Mellis S; Yancopoulos GD; Hamilton JD; MacDonnell S; Hamon SC; Boyapati A; Morton L
    Microbes Infect; 2023 May; 25(4):105081. PubMed ID: 36494054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
    Boussier J; Yatim N; Marchal A; Hadjadj J; Charbit B; El Sissy C; Carlier N; Pène F; Mouthon L; Tharaux PL; Bergeron A; Smadja DM; Rieux-Laucat F; Duffy D; Kernéis S; Frémeaux-Bacchi V; Terrier B
    J Allergy Clin Immunol; 2022 Feb; 149(2):550-556.e2. PubMed ID: 34800432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System.
    Lipcsey M; Persson B; Eriksson O; Blom AM; Fromell K; Hultström M; Huber-Lang M; Ekdahl KN; Frithiof R; Nilsson B
    Front Immunol; 2021; 12():627579. PubMed ID: 33692801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center.
    Rodriguez-Nava G; Yanez-Bello MA; Trelles-Garcia DP; Chung CW; Egoryan G; Friedman HJ
    Med Sci Monit; 2020 Nov; 26():e928754. PubMed ID: 33188161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
    Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
    J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D Status Is Associated With In-Hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients.
    Angelidi AM; Belanger MJ; Lorinsky MK; Karamanis D; Chamorro-Pareja N; Ognibene J; Palaiodimos L; Mantzoros CS
    Mayo Clin Proc; 2021 Apr; 96(4):875-886. PubMed ID: 33714594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.